Protein Variants | Comment | Organism |
---|---|---|
K219A | mutation in conserved pyridoxal phosphate-binding site, loss of activity. Mutant is nearly as effective aswild-type Bat1 or Bat2 at partially suppressing the rapamycin recovery and TORC1 activity defects of the Bat1 bat2 mutant | Saccharomyces cerevisiae |
K219R | mutation in conserved pyridoxal phosphate-binding site, loss of activity. Mutant is nearly as effective aswild-type Bat1 or Bat2 at partially suppressing the rapamycin recovery and TORC1 activity defects of the Bat1 bat2 mutant | Saccharomyces cerevisiae |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Saccharomyces cerevisiae | 5739 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Saccharomyces cerevisiae | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
Bat1 | - |
Saccharomyces cerevisiae |
General Information | Comment | Organism |
---|---|---|
physiological function | branched-chain aminotransferase yeast mutants exhibit severely compromised target of rapamycin complex TORC1 activity, which is partially restored by expression of isoofrm Bat1 active site mutants, implicating both catalytic and structural roles of branched-chain aminotransferases in TORC1 control. Bat1 interacts with branched-chain amino acid metabolic enzymes and, in a leucine-dependent fashion, with the tricarboxylic acid-cycle enzyme aconitase. Branched-chain aminotransferase mutation perturbs tricarboxylic acid-cycle intermediate levels, consistent with a tricarboxylic acid-cycle block, and results in low ATP levels, activation of AMPK, and TORC1 inhibition | Saccharomyces cerevisiae |